122 related articles for article (PubMed ID: 9291403)
1. Ductal adenocarcinoma of the body and tail of the pancreas.
Sperti C; Pasquali C; Pedrazzoli S
J Am Coll Surg; 1997 Sep; 185(3):255-9. PubMed ID: 9291403
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
Conlon KC; Klimstra DS; Brennan MF
Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
4. Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas.
Hirata K; Sato T; Mukaiya M; Yamashiro K; Kimura M; Sasaki K; Denno R
Arch Surg; 1997 Jul; 132(7):771-6; discussion 777. PubMed ID: 9230864
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the body and tail of the pancreas: is curative resection justified?
Dalton RR; Sarr MG; van Heerden JA; Colby TV
Surgery; 1992 May; 111(5):489-94. PubMed ID: 1317976
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
Nitecki SS; Sarr MG; Colby TV; van Heerden JA
Ann Surg; 1995 Jan; 221(1):59-66. PubMed ID: 7826162
[TBL] [Abstract][Full Text] [Related]
8. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
9. Ductal adenocarcinoma of the pancreas: clinicopathologic features and survival.
Sperti C; Bonadimani B; Pasquali C; Piccoli A; Cappellazzo F; Rugge M; Pedrazzoli S
Tumori; 1993 Oct; 79(5):325-30. PubMed ID: 8116075
[TBL] [Abstract][Full Text] [Related]
10. Favourable prognosis of cystadeno- over adenocarcinoma of the pancreas after curative resection.
Ridder GJ; Maschek H; Klempnauer J
Eur J Surg Oncol; 1996 Jun; 22(3):232-6. PubMed ID: 8654602
[TBL] [Abstract][Full Text] [Related]
11. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas.
Christein JD; Kendrick ML; Iqbal CW; Nagorney DM; Farnell MB
J Gastrointest Surg; 2005; 9(7):922-7. PubMed ID: 16137585
[TBL] [Abstract][Full Text] [Related]
12. Impact of laparoscopic staging in the treatment of pancreatic cancer.
Jimenez RE; Warshaw AL; Rattner DW; Willett CG; McGrath D; Fernandez-del Castillo C
Arch Surg; 2000 Apr; 135(4):409-14; discussion 414-5. PubMed ID: 10768705
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
[TBL] [Abstract][Full Text] [Related]
14. [Surgical therapy of pancreatic carcinoma--indications and results].
Farthmann EH; Ruf G
Schweiz Rundsch Med Prax; 1994 Aug; 83(32):870-2. PubMed ID: 8091056
[TBL] [Abstract][Full Text] [Related]
15. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan.
Mukaiya M; Hirata K; Satoh T; Kimura M; Yamashiro K; Ura H; Oikawa I; Denno R
World J Surg; 1998 Mar; 22(3):248-52; discussion 252-3. PubMed ID: 9494416
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological features of t1 ductal adenocarcinoma of the pancreas.
Takao S; Shinchi H; Sha K; Natsugoe S; Maenohara S; Suenaga T; Nishimata Y; Aikou T
Hepatogastroenterology; 1999; 46(25):498-503. PubMed ID: 10228850
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
[TBL] [Abstract][Full Text] [Related]
19. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
Tascilar M; Skinner HG; Rosty C; Sohn T; Wilentz RE; Offerhaus GJ; Adsay V; Abrams RA; Cameron JL; Kern SE; Yeo CJ; Hruban RH; Goggins M
Clin Cancer Res; 2001 Dec; 7(12):4115-21. PubMed ID: 11751510
[TBL] [Abstract][Full Text] [Related]
20. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
